HOOKIPA Pharma (HOOK)
(Delayed Data from NSDQ)
$4.74 USD
+0.02 (0.42%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $4.74 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth F Momentum F VGM
HOOKIPA Pharma Inc. (HOOK) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$43.50 | $60.00 | $24.00 | 821.61% |
Price Target
Based on short-term price targets offered by four analysts, the average price target for HOOKIPA Pharma Inc. comes to $43.50. The forecasts range from a low of $24.00 to a high of $60.00. The average price target represents an increase of 821.61% from the last closing price of $4.72.
Analyst Price Targets (4 )
Broker Rating
HOOKIPA Pharma Inc. currently has an average brokerage recommendation (ABR) of 1.25 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by four brokerage firms. The current ABR compares to an ABR of 1.20 a month ago based on five recommendations.
Of the four recommendations deriving the current ABR, three are Strong Buy and one is Buy. Strong Buy and Buy respectively account for 75% and 25% of all recommendations. A month ago, Strong Buy made up 80%, while Buy represented 20%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 3 | 4 | 4 | 3 | 3 |
Buy | 1 | 1 | 1 | 1 | 1 |
Hold | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.25 | 1.20 | 1.20 | 1.25 | 1.25 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
7/26/2024 | JMP Securities | Roy Buchanan | Not Available | Strong Buy |
6/5/2024 | H.C. Wainwright & Co. | Arthur He | Strong Buy | Strong Buy |
4/1/2024 | Truist Securities | Asthika S Goonewardene | Strong Buy | Strong Buy |
3/25/2024 | Not Identified | Not Identified | Moderate Buy | Moderate Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.25 |
ABR (Last week) | 1.20 |
# of Recs in ABR | 4 |
Average Target Price | $43.50 |
LT Growth Rate | NA |
Industry | Medical - Biomedical and Genetics |
Industry Rank by ABR | 79 of 253 |
Current Quarter EPS Est: | -1.90 |
HOOK FAQs
HOOKIPA Pharma Inc. (HOOK) currently has an average brokerage recommendation (ABR) of 1.25 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 4 brokerage firms.
The average price target for HOOKIPA Pharma Inc. (HOOK) is $43.50. The current on short-term price targets is based on 1 reports.
The forecasts for HOOKIPA Pharma Inc. (HOOK) range from a low of $24 to a high of $60. The average price target represents a increase of $817.72 from the last closing price of $4.74.
The current UPSIDE for HOOKIPA Pharma Inc. (HOOK) is 817.72%
Based on short-term price targets offered by four analysts, the average price target for HOOKIPA Pharma Inc. comes to $43.50. The forecasts range from a low of $24.00 to a high of $60.00. The average price target represents an increase of 821.61% from the last closing price of $4.72.